Evidence map›Paper›PMID 42886777›Full record

ArticleScience advances2026

Chemogenetic ubiquitin E1 inhibitor TAK-243 CRISPR screen uncovers HAPSTR1/HUWE1 axis in chromatin proteostasis and cell cycle control.

Nila K van Overbeek, Linda Clijsters, Martina Wirth, Ilona J de Graaf, Klaas de Lint, Sidrit Uruci, Amina F A S Teunisse, Vyacheslav Akimov, Arnoud H de Ru, Maja Vukic and 8 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Nila K van OverbeekDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-0431-3595
Linda ClijstersDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-3118-9702
Martina WirthDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-3210-8644
Ilona J de GraafDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0003-4957-2424
Klaas de LintDepartment of Human Genetics, Amsterdam University Medical Center, Amsterdam, Netherlands.ORCID 0000-0001-7134-444X
Sidrit UruciDepartment of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0003-3248-7960
Amina F A S TeunisseDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.
Vyacheslav AkimovDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-8377-1761
Arnoud H de RuCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.ORCID 0009-0002-1166-4059
Maja VukicDepartment of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-7555-7706
Idil KirdökDepartment of Human Genetics, Amsterdam University Medical Center, Amsterdam, Netherlands.ORCID 0000-0002-6325-9218
Lucia DaxingerDepartment of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0001-6557-6201
Peter A van VeelenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-7898-9408
Blagoy BlagoevDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-3596-0066
Martijn S LuijsterburgDepartment of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0001-5796-6541
Rob M F WolthuisDepartment of Human Genetics, Amsterdam University Medical Center, Amsterdam, Netherlands.ORCID 0000-0002-3109-1588
Ilana BerlinDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0001-7917-1475
Alfred C O VertegaalDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-7989-0493

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we sought to comprehensively map ubiquitin signaling networks at the crossroads of cellular proliferation and proteostasis, both crucial in cancer. Genome-wide CRISPR knockout screening in the presence of the ubiquitin E1 inhibitor TAK-243 identified 239 genes whose ablation sensitizes cells to ubiquitination blockade. Follow-up studies reveal a role for the nuclear protein, C16orf72/HECT, UBA, and WWE domain containing E3 ubiquitin protein ligase 1 (HUWE1)-Associated Protein modifying Stress Responses (HAPSTR1), in chromatin proteostasis and DNA replication. We show that HAPSTR1 recruits the E3 ligase HUWE1 to the chromatin, keeping the chromatin-associated proteome in check, and is itself turned over by HUWE1 during cell cycle progression. Structural modeling of the HAPSTR1/HUWE1 complex, supported by mutational analysis, demonstrates that loss of HUWE1 binding renders HAPSTR1 unable to support cellular proliferation when ubiquitin signaling is suppressed. Consequently, HAPSTR1 ablation impairs clearance of chromatin-associated proteins, triggering global transcriptional and proteostatic adaptations. Under diminished ubiquitin signaling, these adaptive mechanisms give way to replication stress and premature S phase entry, culminating in cell cycle collapse and DNA damage. Our findings uncover protein networks exhibiting synthetic lethality with ubiquitin signaling blockade and highlight vulnerabilities of actively proliferating cells to proteostatic imbalance at the chromatin.

Indexed as

Cell Cycle CheckpointsChromatinCRISPR-Cas SystemsProteostasisUbiquitin-Protein LigasesCell ProliferationDNA ReplicationHumansPyrazolesPyrimidinesSignal TransductionSulfidesSulfonamidesTumor Suppressor ProteinsUbiquitinationChromatinHUWE1 protein, humanPyrazolesPyrimidinesSulfidesSulfonamidesTAK-243Tumor Suppressor ProteinsUbiquitin-Protein Ligases

Identifiers

PMID42886777
PMCPMC13674506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.